Lycopene is a red carotenoid with
remarkable antioxidant
activity,
which has been widely used in food, cosmetics, medicine, and other
industries. Production of lycopene in Saccharomyces
cerevisiae provides an economic and sustainable means.
Many efforts have been done in recent years, but the titer of lycopene
seems to reach a ceiling. Enhancing the supply and utilization of
farnesyl diphosphate (FPP) is generally regarded as an efficient strategy
for terpenoid production. Herein, an integrated strategy by means
of atmospheric and room-temperature plasma (ARTP) mutagenesis combined
with H2O2-induced adaptive laboratory evolution
(ALE) was proposed to improve the supply of upstream metabolic flux
toward FPP. Enhancing the expression of CrtE and
introducing an engineered CrtI mutant (Y160F&N576S)
increased the utilization of FPP toward lycopene. Consequently, the
titer of lycopene in the strain harboring the Ura3 marker was increased by 60% to 703 mg/L (89.3 mg/g DCW) at the shake-flask
level. Eventually, the highest reported titer of 8.15 g/L of lycopene
in S. cerevisiae was achieved in a
7 L bioreactor. The study highlights an effective strategy that the
synergistic complementarity of metabolic engineering and adaptive
evolution facilitates natural product synthesis.